Mounib Elchebly,Paul Payette,Eva Michaliszyn,Wanda Cromlish,Susan Collins,Ailsa Lee Loy,Denis Normandin,Alan Cheng,Jean Himms–Hagen,Chi‐Chung Chan,Chidambaram Ramachandran,Michael J. Gresser,Michel L. Tremblay,Brian P. Kennedy
出处
期刊:Science [American Association for the Advancement of Science (AAAS)] 日期:1999-03-05卷期号:283 (5407): 1544-1548被引量:2172
Protein tyrosine phosphatase–1B (PTP-1B) has been implicated in the negative regulation of insulin signaling. Disruption of the mouse homolog of the gene encoding PTP-1B yielded healthy mice that, in the fed state, had blood glucose concentrations that were slightly lower and concentrations of circulating insulin that were one-half those of their PTP-1B +/+ littermates. The enhanced insulin sensitivity of the PTP-1B −/− mice was also evident in glucose and insulin tolerance tests. The PTP-1B −/− mice showed increased phosphorylation of the insulin receptor in liver and muscle tissue after insulin injection in comparison to PTP-1B +/+ mice. On a high-fat diet, the PTP-1B −/− and PTP-1B +/− mice were resistant to weight gain and remained insulin sensitive, whereas the PTP-1B +/+ mice rapidly gained weight and became insulin resistant. These results demonstrate that PTP-1B has a major role in modulating both insulin sensitivity and fuel metabolism, thereby establishing it as a potential therapeutic target in the treatment of type 2 diabetes and obesity.